Drugging the Cancer Kinome: Progress and Challenges in Developing Personalized Molecular Cancer Therapeutics
Author:
Publisher
Cold Spring Harbor Laboratory
Subject
Genetics,Molecular Biology,Biochemistry
Reference168 articles.
1. Adams J. 2002. Proteasome inhibition: A novel approach to cancer therapy. Trends Mol. Med. (suppl.) 8: S49.
2. Al Saffar N.M.S., Troy H., Ramirez de Molina A., Jackson L.E., Madhu B., Griffths J.R., Leach M.O., Workman P., Lacal J.C., Judson I.R., and Chung Y.L. 2005. Non-invasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res. (in press).
3. A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer;Journal of Clinical Medicine;2024-05-26
2. Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy;Frontiers in Genetics;2023-12-14
3. Emerging Role of Structural and Systems Biology in Anticancer Therapeutics;Systems Biomedicine Approaches in Cancer Research;2022
4. High Content Screening of Small Molecule Modulators Targeting Heat Shock Response Pathway;Heat Shock Proteins and Stress;2018
5. Measuring Kinase Activity—A Global Challenge;Journal of Cellular Biochemistry;2017-05-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3